LAVAL, Quebec, July 10, 2017 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to release second quarter 2017 financial results on Tuesday, Aug. 8, 2017. The Company will host a conference call and live webcast at 8:00 a.m. EDT to discuss the results and provide a business update. All materials will be made available on the investor relations portion of the corporate website before the start of the conference call.
Conference Call Details
|
Date |
Tuesday, Aug. 8, 2017 |
| Time |
8:00 a.m. EDT |
| Webcast |
|
| Participant Event Dial-in |
(877) 876-8393 (North America) |
| (443) 961-0178 (International) |
|
| Participant Passcode |
35736021 |
| Replay Dial-in |
(855) 859-2056 (North America) |
| (404) 537-3406 (International) |
|
| Replay Passcode |
31833 (replay available until Oct. 8, 2017) |
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
| Investor Contacts: |
||
| Arthur Shannon |
Elif McDonald |
|
| 514-856-3855 |
514-856-3855 |
|
| 877-281-6642 (toll free) |
877-281-6642 (toll free) |
| Media Contact: |
|
| Lainie Keller |
|
| 908-927-0617 |
SOURCE Valeant Pharmaceuticals International, Inc.
Share this article